Improved brain MRI indices in the acute brain stem infarct sites treated with hydroxyl radical scavengers, Edaravone and hydrogen, as compared to Edaravone alone. A non-controlled study.
Hirohisa Ono, Yoji Nishijima, Naoto Adachi, Shigekuni Tachibana, Shiroh Chitoku, Shigeo Mukaihara, Masaki Sakamoto, Yohei Kudo, Jun Nakazawa, Kumi Kaneko, Hiroshi Nawashiro · Medical gas research · 2011
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In 26 patients, administration of hydroxyl radical scavengers in acute stage of brainstem infarction improved MRI indices against the natural course. These findings add human evidence supporting molecular hydrogen's therapeutic potential for Alzheimer's disease.
What the Findings Mean
H2HUBB reviewed how hydrogen-rich water affected the outcomes measured in 26 patients. Administration of hydroxyl radical scavengers in acute stage of brainstem infarction improved MRI indices against the natural course.
What the Researchers Studied
The researchers studied 26 patients. The study used a human clinical study.
What Effects Did Molecular Hydrogen Have?
Source-reported hydrogen concentration: 1.6 mg/L H₂; Source-reported hydrogen exposure: 1.6 mg/L H₂. Administration of hydroxyl radical scavengers in acute stage of brainstem infarction improved MRI indices against the natural course. These findings may imply the need for more frequent daily administration of hydroxyl scavenger, or possible additional hydrogen effects on scavenger mechanisms. hydrogen-rich water improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress.
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential for Alzheimer's disease and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a human clinical study. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as human clinical study with human clinical evidence. The research population or model was 26 patients. The reported sample size was 26. The study used a human clinical study. The hydrogen delivery method was hydrogen-rich water. The source-reported hydrogen concentration was 1.6 mg/L H₂. The source-reported hydrogen exposure was 1.6 mg/L H₂.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base. The original scholarly source is available at https://europepmc.org/article/PMC/PMC3231971.